ABUJA, Oct 14 (Reuters) – Nigeria has acquired 501,600 doses of AstraZeneca’s (AZN.L) COVID-19 vaccine from the French authorities by means of the COVAX vaccine-sharing facility, a senior well being official mentioned on Thursday.
Faisal Shuaib, head of the National Primary Health Care Development Agency, mentioned the nation additionally acquired 434,400 doses of Johnson and Johnson (JNJ.N) vaccine from the African Union.
Both provides had been acquired final week, Shuaib mentioned, including that extra had been anticipated by means of the COVAX facility and the African Union.
The COVAX facility, backed by the World Health Organization and the GAVI vaccine alliance, goals to safe billions of doses for lower-income international locations by the top of 2021.
About 2.3% of Nigerians or 2.54 million individuals have been absolutely vaccinated as of Thursday, whereas 4.7% of the inhabitants have acquired at the least one dose of COVID-19 vaccine, Shuaib mentioned.
“With more vaccines arriving in the country, it is my fervent hope that more people will turn up … so that Nigeria can rapidly progress towards attaining herd immunity,” Shuaib mentioned.
From Dec. 1, Nigerian civil servants can be require to present proof of vaccination in opposition to COVID-19 or a destructive take a look at for the illness to acquire entry to their places of work, a presidential committee has mentioned. learn extra
Nigeria, which has not examined extensively for COVID-19, has to this point recorded 208,404 confirmed infections and a pair of,761 deaths from the virus.